Travere Therapeutics to Present Abstracts at the Society for Inherited Metabolic Disorders and Genetic Metabolic Dieticians International

Posters to be presented highlighting research investigating pegtibatinase as the first potential disease-modifying treatment for classical homocystinuriaSAN DIEGO, April 04, 2024 -- Travere...

Related Keywords

North Carolina ,United States ,Charlotte ,Jula Inrig ,Genetic Metabolic Dieticians International ,Nasdaq ,Exchange Commission ,Travere Therapeutics Inc ,European Commission ,Association Between Homocysteine ,Clinical Care Research ,Society For Inherited Metabolic Disorders ,Inherited Metabolic Disorders ,Results From ,Classical Homocystinuria ,Using Pegtibatinase ,Novel Investigational Enzyme Replacement ,Investigational Enzyme Replacement Therapy ,For The Treatment ,Innovative Therapies ,Retrospective Claims Analysis ,Between Homocysteine ,Clinical Outcomes ,Systematic Literature ,Novel Investigational Enzyme Replacement Therapy ,Dietary Management ,Clinical Trials ,Dietary Management Strategies ,Breakthrough Therapy ,Rare Pediatric Disease ,Fast Track ,Orphan Drug ,Travere Therapeutics ,Private Securities Litigation Reform Act ,